Transdermal preparation containing a loratidine metabolite with antihistaminic activity
US6165498A · kind A · utility
1Cited by
3References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 1998 |
| Grant date | Dec 26, 2000 |
| Priority date | — |
| Expiry date | Mar 23, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4545
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A transdermal patch contains an active loratidine metabolite contained with a polyacrylate polymer matrix. The transdermal patch provides pharmaceutically useful transdermal flux rates over time.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.